Ziekenhuis Aan De Stroom

2 trials 1 recruiting Academic / non-commercial

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

1 Recruiting

1 Completed trials

2 Countries active

8 Unique IMPs

100% Results reported

Phase II/III

Phase II

Phase II/III: 1 Phase II: 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

DEGARELIX 2 GOSERELIN ACETATE 2 LEUPRORELIN ACETATE 2 TRIPTORELIN 2 APALUTAMIDE 1 DAROLUTAMIDE 1 DOCETAXEL 1 RELUGOLIX 1

All trials

2 total

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial Recruiting

2022-501551-90-00 Phase II/III 2 countries DAROLUTAMIDE; DEGARELIX; DOCETAXEL; GOSERELIN ACETATE; LEUPRORELIN ACETATE; RELU…
A phase II, randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy (ADT) w… Ended

2024-512023-37-00 Phase II 1 country APALUTAMIDE; DEGARELIX; GOSERELIN ACETATE; LEUPRORELIN ACETATE; TRIPTORELIN

Showing 1–2 of 2 trials

← All sponsors A–Z